An interventional study of Ultrasound-Guided PECS II Block and Lidocaine (without epinephrine) in Breast Surgery and Lidocaine Infusion, sponsored by Istanbul Medeniyet University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Istanbul Medeniyet University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,099 studies in Pain, Postoperative with a site in Turkey — 264 open to participants now, 297 under way, none of them phase 3. Pain, Postoperative · Turkey.
Among the 1,099 studies in Pain, Postoperative with a site in Turkey, this one is the 463rd largest by enrollment of the 884 interventional ones that give a count, is one of 133 that started in 2023, is one of 815 with no phase, and was the 1,097th registered.
5,654 studies on the registry are indexed under Pain, Postoperative; 1,233 are open to participants now.
Browse Pain, Postoperative studies →264 of the 1,099 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:
Konya City Hospital · Sites in Turkey
Ages 18–65
Kocaeli City Hospital · Sites in Turkey
Ages 8–18 · Healthy volunteers
Bursa City Hospital · Sites in Turkey
Ages 18–85 · Women only
Van Training and Research Hospital · Sites in Turkey
Ages 18–65
Istanbul University · Sites in Turkey
Ages 1–12
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 676 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 327 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.
This study: 18 Years to 75 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,099 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 4 · Phase 3 2 · Phase 4 59
First in 2009; this study’s year is marked. 133 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 66 is below the median of 75 across 4,835 interventional studies indexed under Pain, Postoperative.
Median enrollment 70 across the 884 interventional studies, 80 across the 215 observational. Of the 751 that completed or were terminated, 9 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 1,099 have an industry lead sponsor. The 10 most frequent:
Istanbul Medeniyet University is the lead sponsor of 193 studies on the registry; 17 are open to participants now.
Istanbul Medeniyet University has 7 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
134 of the studies in Pain, Postoperative with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07659990Ferit YetikRISS Versus SPSIP Block in Modified Radical Mastectomy | 2026-11 |
| NCT07524673Cumhuriyet UniversityComprasion of SPSIP and Rhomboid Intercostal Plan Blocks on VATS | 2026-11 |
| NCT07650877Ankara City Hospital BilkentComparison of the Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block | 2026-11-20 |
| NCT07436806Medipol UniversitySPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery | 2026-11-20 |
| NCT06869967Kocaeli UniversityEvaluation of Postoperative Pain Control in Ear Surgery | 2026-11-25 |
Add all 134 to your calendar (.ics) → With an account.
Among the 1,099 studies in Pain, Postoperative with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial was to compare two methods of pain control in adults having breast-conserving surgery. The study compared a chest wall nerve block called a PECS II block with lidocaine given through a vein during surgery.
The main question it aimed to answer was:
Researchers compared participants who received a PECS II block before surgery with participants who received intravenous lidocaine during surgery.
Participants:
Inclusion Criteria: Age 18 to 75 years
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received an ultrasound-guided PECS II block at least 30 minutes before surgery. A total of 20 mL of 0.25% bupivacaine was injected between the pectoralis minor and serratus anterior muscles, followed by 10 mL of 0.25% bupivacaine between the pectoralis major and pectoralis minor muscles.
Procedure: Ultrasound-Guided PECS II Block
Participants received intravenous lidocaine beginning immediately before the surgical incision. A bolus dose of 1.5 mg/kg lidocaine was given intravenously, followed by a continuous intraoperative infusion of 2 mg/kg/hour until the end of surgery.
Drug: Lidocaine (without epinephrine)
An ultrasound-guided PECS II block was performed at least 30 minutes before surgery. A total of 20 mL of 0.25% bupivacaine was injected between the pectoralis minor and serratus anterior muscles, followed by 10 mL of 0.25% bupivacaine between the pectoralis major and pectoralis minor muscles.
Also known as: Interpectoral and Pectoserratus Plane Block
lidocaine was administered intravenously immediately before the surgical incision as a 1.5 mg/kg bolus, followed by a continuous intraoperative infusion of 2 mg/kg/hour until the end of surgery.
Postoperative tramadol consumption
Cumulative tramadol consumption (mg) via patient-controlled analgesia (1 mg/mL, 10 mg bolus, 6-minute lockout, no background infusion). Follow-up was planned for 24 hours after surgery; because patients were discharged at postoperative hour 12, consumption was recorded at 1, 4, 8 and 12 hours.
Time frame: Up to 12 hours after surgery
Postoperative Pain Score
ain intensity assessed by a blinded anesthesiologist using the 0-10 Numeric Rating Scale (0 = no pain, 10 = worst imaginable pain). An additional assessment at 24 hours was planned but could not be performed because patients were discharged at postoperative hour 12.
Time frame: 15 minutes and 1, 4, 8 and 12 hours after surgery
Ran from Nov 2023 to primary completion in Jan 2024, 2 months.
Of 2,097 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 2 months is below that.
Counting every sponsor, half of 2,110 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Medeniyet University →